CAPITALHILL ADVISORY for NOVARTIS PHARMACEUTICALS PTY LTD ( AUSTRALIA)
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Privileged & Confidential The Australian Government's policy of initiating court proceedings to recovered damages from innovative pharmaceutical companies in cases where patents covering pharmaceutical benefits scheme (PBS)- listed medicines have been found invalid following an initial grant of an interlocutory injunction which delayed the launch of generic products
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICHOLAS CAMPBELL New | — |
Taxation/Internal Revenue Code TAX
Privileged & Confidential The Australian Government's policy of initiating court proceedings to recovered damages from innovative pharmaceutical companies in cases where patents covering pharmaceutical benefits scheme (PBS)- listed medicines have been found invalid following an initial grant of an interlocutory injunction which delayed the launch of generic products
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICHOLAS CAMPBELL New | — |
Economics/Economic Development ECN
Privileged & Confidential The Australian Government's policy of initiating court proceedings to recovered damages from innovative pharmaceutical companies in cases where patents covering pharmaceutical benefits scheme (PBS)- listed medicines have been found invalid following an initial grant of an interlocutory injunction which delayed the launch of generic products
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICHOLAS CAMPBELL New | — |
Government Issues GOV
Privileged & Confidential The Australian Government's policy of initiating court proceedings to recovered damages from innovative pharmaceutical companies in cases where patents covering pharmaceutical benefits scheme (PBS)- listed medicines have been found invalid following an initial grant of an interlocutory injunction which delayed the launch of generic products
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICHOLAS CAMPBELL New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| NOVARTIS INT. | Switzerland | Switzerland | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.